Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

E-ISSN： 2212-3970|11|2|184-196

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.11, Iss.2, 2016-04, pp. : 184-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aldo-Keto Reductase Family 1 Member B1 Inhibitors: Old Drugs with New Perspectives

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 246-253

Bentham Science Publishers

Access to resources Recommend Favorite

Cisplatin resistance by induction of aldoketo reductase family 1 member C2 in human bladder cancer cells

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 674-678

Spandidos Publications

Access to resources Recommend Favorite

Chk1 Inhibitors for Novel Cancer Treatment

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 4, 2006-07 ,pp. : 377-388

Bentham Science Publishers

Access to resources Recommend Favorite

Upregulation of the B7/CD28 family member B7-H3 in bladder cancer

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1420-1424

Spandidos Publications

Access to resources Recommend Favorite

Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 79-101

Bentham Science Publishers

Access to resources Recommend Favorite